ARTICLE | Company News
Summit Therapeutics, University of Oxford deal
November 23, 2015 8:00 AM UTC
Summit and the University of Oxford’s Isis Innovation Ltd. tech transfer arm extended through November 2019 a 2013 deal to develop oral utrophin modulators to treat Duchenne muscular dystrophy (DMD)....